Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Debord

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Pharmacokinetics|March 14, 2008
Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategiesNoël Zahr, Zahir Amoura, Jean Debord, et al.
Clinical Pharmacokinetics|July 21, 2005
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetilAurélie Prémaud, Jean Debord, Annick Rousseau, et al.
Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.
Therapeutic Drug Monitoring|July 3, 2009
Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipientsPierre Marquet, Franck Saint-Marcoux, Aurélie Prémaud, et al.
Clinical Pharmacokinetics|November 24, 2020
Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant RecipientsPierre Marquet, Alexandre Destère, Caroline Monchaud, et al.
Therapeutic Drug Monitoring|February 15, 2017
A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 ActivityJean-Baptiste Woillard, Jean Debord, Isabelle Benz-de-Bretagne, et al.
Plos One|March 13, 2020
Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipientsCamille Tron, Jean-Baptiste Woillard, Pauline Houssel-Debry, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Pharmacokinetics|March 14, 2008
Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategiesNoël Zahr, Zahir Amoura, Jean Debord, et al.
Clinical Pharmacokinetics|July 21, 2005
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetilAurélie Prémaud, Jean Debord, Annick Rousseau, et al.
Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.
Therapeutic Drug Monitoring|July 3, 2009
Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipientsPierre Marquet, Franck Saint-Marcoux, Aurélie Prémaud, et al.
Clinical Pharmacokinetics|November 24, 2020
Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant RecipientsPierre Marquet, Alexandre Destère, Caroline Monchaud, et al.
Therapeutic Drug Monitoring|February 15, 2017
A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 ActivityJean-Baptiste Woillard, Jean Debord, Isabelle Benz-de-Bretagne, et al.
Plos One|March 13, 2020
Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipientsCamille Tron, Jean-Baptiste Woillard, Pauline Houssel-Debry, et al.
Pageof 4